Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs

The World Health Organization (WHO) recommends periodic assessment of the therapeutic efficacy of praziquantel (PZQ) to detect reduced efficacy that may arise from drug resistance in schistosomes. In this multi-country study (2014), we assessed the therapeutic efficacy of a single oral dose of PZQ (...

Descripción completa

Detalles Bibliográficos
Autores principales: Levecke, B., Vlaminck, J., Andriamaro, L., Ame, S., Belizario, V., Degarege, A., Engels, D., Erko, B., Garba, A.D., Kaatano, G.M., Mekonnen, Z., Montresor, A., Olliaro, P., Pieri, O.S., Sacko, M., Sam-Wobo, S.O., Tchuem Tchuenté, L.A., Webster, J.P., Vercruysse, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595844/
https://www.ncbi.nlm.nih.gov/pubmed/33125936
http://dx.doi.org/10.1016/j.ijpddr.2020.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595844/
https://www.ncbi.nlm.nih.gov/pubmed/33125936
http://dx.doi.org/10.1016/j.ijpddr.2020.10.003

Ejemplares similares